Glaucoma, capillaries and pericytes. 3. Peptide hormone binding and influence on pericytes

Ophthalmologica

Volumn 210, Issue 5, 1996, Pages 269-275

  Ferrari Dileo, Gabryleda ^a   Davis, Barry ^a   Anderson, Douglas R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin; Blood flow regulation; Capillaries; Cell culture; Glaucoma; Pericytes; Retina; Vasoactive intestinal peptide

Indexed keywords

ANGIOTENSIN; FORSKOLIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ARTICLE; CAPILLARY; CATTLE; CELL CULTURE; GLAUCOMA; NONHUMAN; PERICYTE; RETINA BLOOD FLOW;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BINDING SITES; BLOOD FLOW VELOCITY; CAPILLARIES; CAPILLARY RESISTANCE; CATTLE; CELLS, CULTURED; CYCLIC AMP; GLAUCOMA; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; OPTIC NERVE; RETINAL VESSELS; SARALASIN; VASOACTIVE INTESTINAL PEPTIDE; VASOCONSTRICTOR AGENTS;

EID: 0029817076     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000310724     Document Type: Article

References (42)

1. Anderson DR: The posterior segment of glaucomatous eyes: in Liitjen-Drecoll E, (ed): Basic Aspects of Glaucoma Research, New York, Schattauer, 1982. pp 167-190.
2. Anderson DR: The mechanisms of damage of the optic nerve: in Krieglstein GK, Lcydhecker W (eds): Glaucoma Update II, New York, Springer, 1983. pp 89-93.
3. Sossi N, Anderson DR: Blockage of axonal transport in optic nerve induced by elevation of intracular pressure: Effect of arterial hypertension induced by angiotensin I, Arch Ophthalmol 1983;101:94-97.
4. Wei EP, Kontos HA, Patterson JL, Jr.: Vasoconstrictive effect of angiotensin on pial arteries, Stroke 1978:9:487-489.
5. Whallcy ET, Wahl M: Cerebrovascular reactivity to angiotensin and angiotensin converting enzyme activity in cerebrospinal fluid, Brain Res 1988;438:1-7.
6. Joyner WL, Young R, Blank D, Eccleston-Joyn-er CA, Gilmore JP: In vivo microscopy of the cerebral microcirculation using neonatal allografts in hamsters, Circ Res 1988:63:758-766.
7. Haberl RE, Anneser F, Villringer A, Einhaiiptl KM: Angiotensin II induces endothelium-dependent vasodilation of rat cerebral arterioles, Am J Physiol 1990:258:H1840-H1846.
8. Dacey RG, Bassett JE: Control of intraccrebral arteriolar smooth muscle by vasoactive peptides (abstract), J Cerebr Blood Flow Metab 1987;7(suppl 1):5592.
9. Itoh T, Sasaguri T, Makita Y, Kanmura Y, Kuriyanta H: Mechanisms of vasodilatation induced by vasoactive intestinal polypeptide in rabbit mesenteric artery, Am J Physiol 1985:249(2. pt 2):H231-H240.
10. Lecff F, Saito A, Bcrenzin I: Vasoactive intestinal polypeptide-like infstance: The potential transmitter for cerebral vasodilation, Science 1984:224:898-901.
11. Edvinsson L, Fredholm BB, Hamel E, Jansen I, Verrecchia C: Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat, Neurosci Lett 1985:58:213-217.
12. Ganz P, Sandroek AW, Landis SC, Leopold J, Gimbrone MA Jr., Alexander RW: Vasoactive intestinal peptide: Vasodilation and cyclic AMP generation, Am J Physiol 1986:250(5. pt 2): H755-H760.
13. Lasater EM, Walling KJ, Dowling JE: Vasoactive intestinal peptide alters membrane potential and cyclic nucleotide levels in retinal horizontal cells, Science 1983:221:1070-1072.
14. Magistretti PJ, Schordcret M: VIP noradrenaline act synergistically to increase cyclic AMP in cerebral cortex, Nature 1984;308:280-282.
15. Huang M, Rorstad OP: Effects of vasoactive intestinal polypeptide, monoamines, prostaglandins, and 2-chloroadenosine on adenylate cyclase in rat cerebral microvessels, J Neurochem 1983:40:719-726.
16. Scott J, Baum BJ: Involvement of cyclic AMP and calcium in exocrine protein secretion induced by vasoactive intestinal polypeptide in rat parotid cells, Biochim Biophys Acta 1985: 847:255-262.
17. Ferrari-Dilco G, Davis EB, Anderson DR: Angiotensin binding sites in bovine and human retinal blood vessels, Invest Ophthalmol Vis Sci 1987:28:1747-1751.
18. Ferrari-Dileo G, Davis EB, Anderson DR: Angiotensin II binding receptors in retinal and optic nerve head blood vessels: an autoradiographic approach, Invest Ophthalmol Vis Sci 1991:32:21-26.
19. Roekwood EJ, Fantes F, Davis EB, Anderson DR: The response of retinal vasculature to-angiotensin, Invest Ophthalmol Vis Sci 1987: 28:676-682.
20. Nyborg NC, Nielsen PJ, Prieto D, Benedito S: Angiotensin II does not contract bovine retinal resistance arteries in vitro, Exp Eye Res 1990: 50:469-474.
21. Ferrari-Dileo G, Davis EB, Anderson DR: Effects of cholinergic and adrenergic agonists on adenylate cyclase activity of retinal microvascular pericytes in culture, Invest Ophthalmol Vis Sci 1992;33:42-47.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent, J Biol Chem 1951;193:265-275.
23. Harris AK, Wild P, Stopak D: Silicone rubber infstrata: A new wrinkle in the study of cell locomotion, Science 1980;208:177-179.
24. Kelley C, D'Amore P, Ilechtman FIB, Shepro D: Vasoactive hormones and cAMP affect pericyte contraction and stress fibres in vitro, J Muscle Res Cell Motil 1988:9:184-194.
25. Hirata Y, Tomita M, Takata S, Fujita T: Functional receptors for vasoactive intestinal peptide in cultured vascular smooth muscle cells from rat aorta, Biochem Biophys Res Commun 1985: 132:1079-1087.
26. Paul S, Voile DJ, Currie J: Receptor binding of guinea pig and pig vasoactive intestinal peptides in rat lung, Biochem J 1988:254:613-615.
27. Mittag TW, Tormay A, Podos SM: Vasoactive intestinal peptide and intraocular pressure: Adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes, J Pharmacol Exp Titer 1987;241:230-235.
28. Swedlund AP, Rosenzweig SA: Characterization of vasoactive intestinal peptide receptors in retina, Exp Eye Res 1990:51:317-323.
29. Timmermans PBM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RS, Wexler RR, Saye JAM, Smith RD: Angiotensin II receptors and angiotensin II receptor antagonists, Pharmacol Rev 1993:45:205-251.
30. Anand-Srivastava MB: Angiotensin II receptors negatively coupled to adenylate cyclase in rat aorta, Biochem Biophys Res Commun 1983; 117:420-428.
31. Hassid A: Increase of cyclic AMP concentrations in cultured vascular smooth muscle cells by vasoactive peptide hormones: Role of endogenous prostaglandins, J Pharmacol Exp Ther 1986:239:334-339.
32. Nabika T, Nara Y, Yamori Y, Lovenberg W, Endo J: Angiotensin II and phorbol ester enhance isoproterenol and vasoactive intestinal peptide (VIP)-induced cyclic AMP accumulation in vascular smooth muscle cells, Biochem Biophys Res Commun 1985:131:30-36.
33. Malhotra RK, Wakade TD, Wakadc AR: Vasoactive intestinal polypeptide and muscarine mobilize intracellular Ca through breakdown of phosphoinositides to induce catecholamine secretion: role of IP in exocytosis, J Biol Chem 1988;263:2123-2126.
34. Allard LR, Beinfcld MC: Vasoactive intestinal peptide (VIP) inhibits potassium-induced release of cholecystokinin (CCK) from rat cauda-to-putamen but not from cerebral cortex, Neuropeptides 1986:8:287-293.
35. Dodge AB, Hcchtman HB, Shepro D: Microvascular endothelial-derived autacoids regulate pericyte contractility, Cell Motil Cytoskeleton 1981:18:180-188.
36. Sata T, Misra HP, Kubota E, Said SI: Vasoactive intestinal polypeptide relaxes pulmonary artery by an endothelium-independent mechanism, Peptide 1986;7(suppl 1):225-227.
37. Davis JM, Williams KI: Endothelial-dependent relaxant effects of vaso-active intestinal polypeptide and arachidonic acid in rat aortic strips, Prostaglandins 1984:27:195-202.
38. Forster BA, Ferrari-Dileo G, Anderson DR: Adrenergic alpha, and alpha-binding sites are present in bovine retinal blood vessels, Invest Ophthalmol Vis Sci 1987:28:1741-1746.
39. Ferrari-Dileo G, Davis EB, Anderson DR: Biochemical evidence for cholinergic activity in retinal blood vessels, Invest Ophthalmol Vis Sci 1989:30:473-477.
40. Ferrari-Dileo G, Davis EB, Anderson DR: Response of retinal vasculature to phenylephrine, Invest Ophthalmol Vis Sci 1990:31:1181-1182.
41. Ferrari-Dileo G, Davis EB, Anderson DR: Cholinergic binding sites in pericytes isolated from retinal capillaries, Blood Vessels 1991:28:542-546.
42. Ferrari-Dileo G, Ryan JW, Rockwood EJ, Davis EB, Anderson DR: Angiotensin-converting enzyme in bovine, feline and human ocular tissues, Invest Ophthalmol Vis Sci 1988:29:876-881.